Cooperative Agreement 2P2CMS332036
- The Department of Social Services Connecticut was awarded a $7,404,199 Cooperative Agreement by the Centers for Medicare and Medicaid Services under the Cell and Gene Therapy (CGT) Access Model (CFDA 93.885) to increase access to cell and gene therapy for Medicaid members with sickle cell disease in Connecticut. Key activities include: Developing educational materials and raising awareness about cell and gene therapies through collaborations with a community-based organization and four...
- This Cooperative Agreement award, totaling $4,322,370 over 4 years, was provided by the Centers for Medicare and Medicaid Services (CMS) under the Section 206 Consolidated Appropriations Act, 2024: State Planning Grants to Promote Continuity of Care for Medicaid & CHIP Beneficiaries program (CFDA 93.694). The grant supports the Rhode Island Executive Office of Health and Human Services (EOHHS) in developing operational capabilities to ensure incarcerated Medicaid/CHIP beneficiaries receive...
- The North Carolina Department of Health and Human Services (NC DHHS) was awarded a $558,941 cooperative agreement from the Centers for Medicare and Medicaid Services (CMS) under the Cell and Gene Therapy (CGT) Access Model program (CFDA 93.885). The funding will support a set of activities aimed at ensuring the successful implementation of the CGT Access Model in North Carolina, with the overarching goal of strengthening the state's capacity to provide access to cell and gene therapies for...
- The Illinois Department of Healthcare and Family Services (HFS) was awarded a $794,800 Cooperative Agreement under the Centers for Medicare and Medicaid Services' (CMS) Cell and Gene Therapy (CGT) Access Model (CFDA 93.885). The award will fund HFS staff to implement the CGT Access Model, conduct research to evaluate Medicaid customer access to sickle cell disease CGTs and the effectiveness of wraparound services, and support Community-Based Organizations (CBOs) to provide education,...
- The Centers for Medicare and Medicaid Services (CMS) awarded a $2,000,000 Cooperative Agreement to the Rhode Island Executive Office of Health and Human Services (EOHHS) under the Achieving Healthcare Efficiency through Accountable Design (AHEAD) Model (CFDA 93.968). This 6-year award, running from January 1, 2025 to December 31, 2030, will support EOHHS in developing and implementing comprehensive healthcare delivery system reforms focused on preventative care, care coordination, and health...
- The Pennsylvania Department of Human Services (DHS) was awarded a $794,800 Cooperative Agreement from the Centers for Medicare and Medicaid Services (CMS) under the federal Cell and Gene Therapy (CGT) Access Model program (CFDA 93.885). The funding will be used to provide additional services, education, and supports for Medicaid beneficiaries who may be candidates for sickle cell disease gene therapy. DHS will collaborate with the Pennsylvania Department of Health's Sickle Cell Disease...
- The Mississippi Division of Medicaid (DOM) was awarded a $4,912,944 Cooperative Agreement from the Centers for Medicare and Medicaid Services (CFDA 93.885 - Cell and Gene Therapy (CGT) Access Model) to transform healthcare for Medicaid beneficiaries living with sickle cell disease. The funding will support five key initiatives over a 10-year period from August 2025 to December 2035: 1) Travel support for patients and caregivers to access treatment, 2) Individualized care coordination to guide...
- The Department of Health and Human Services Centers for Medicare and Medicaid Services awarded a $2.023 billion Block Grant to the Rhode Island Department of Administration for the Medical Assistance Program (CFDA 93.778) for fiscal year 2022 quarter one. This award provides funding for the Rhode Island Department of Administration's Office of Library & Information Services to administer the state's Medicaid program through September 30, 2022. As outlined in the program description, funds...
- The Centers for Medicare and Medicaid Services awarded a $1.1 million cooperative agreement to the Executive Department of the State of Rhode Island under the State Planning and Establishment Grants for the Affordable Care Act (ACA)’s Exchanges program (CFDA 93.525). The funding will support modernization or updates to Rhode Island's health insurance exchange system to implement provisions of the American Rescue Plan Act that modify premium assistance amounts for certain consumers. As the direct...
- The Department of Health and Human Services Centers for Medicare and Medicaid Services awarded a $90.7 million Block Grant to the Rhode Island Department of Administration for the period of October 1, 2021 through September 30, 2022 under the Medical Assistance Program (CFDA 93.778). The Medical Assistance Program provides financial assistance to states for medical assistance payments on behalf of cash assistance recipients, children, pregnant women, and the aged who meet income and resource...
The Rhode Island Executive Office of Health and Human Services (EOHHS) was awarded a $793,419.04 Cooperative Agreement under the Centers for Medicare and Medicaid Services' (CMS) Cell and Gene Therapy (CGT) Access Model federal grant program (CFDA 93.885). The funding will be used to enhance access to cell and gene therapies and improve care for individuals with sickle cell disease in Rhode Island through a comprehensive, multi-faceted approach. Key activities include developing evidence-based strategies for improving patient care, ensuring equitable access to services, addressing health-related social needs, improving transportation access, conducting public health communication, implementing an academic detailing program for healthcare providers, and tracking patient outcomes. The award period runs from August 1, 2025, through December 31, 2035, with an additional $125,000 in milestone funding for CY 2026.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $223.7k | 8/1/25 |